ZAGENO on Growth Trajectory - Startup Becoming #1 Online Marketplace for Life Science Research Products; Raises $8 Million
(Thomson Reuters ONE) -
BOSTON, Mass., USA, and BERLIN, GERMANY, Oct. 25, 2017 (GLOBE NEWSWIRE)
-- ZAGENO Inc., announces successful Series A investment of $8 Million US
Dollars led by Capnamic Ventures, with Grazia Equity, lead investor in the seed
round, also investing. The investment will be used to fuel growth in the key
markets USA and Europe, by ramping up sales, marketing, and technical
integration teams.
ZAGENO Launching a New Era of Digital Science and Research
"Just two years old, we are experiencing enormous traction, where global leaders
in life science research, such as The Babraham Institute, choose to purchase
life science research products through us," said Co-Founder and CEO of ZAGENO
David Pumberger. "There is a vast need for digitalization in science and
research! We founded ZAGENO with the vision of connecting scientists,
administrative departments, and vendors of biotechnology products via one single
platform, thereby creating a WIN-WIN-WIN-Situation for everybody involved.
Nobody has dared to do that so far," he continued.
What is the WIN-WIN-WIN-situation for scientists, academic research institutes,
researching companies, and equipment vendors? For the first time, ZAGENO enables
scientists in their laboratories to choose crucial products directly via an
online marketplace, from an extensive and high-quality product portfolio.
Currently, researchers from 250+ leading research institutions in the U.S. and
Europe compare products every day on ZAGENO for their experiments and order
directly from across 650+ different vendors. This newly unveiled transparency is
an absolute novelty in the biotech industry and saves costs as well as time for
researchers.
ZAGENO enables straightforward integration of ordering and purchasing processes
into existing software systems. And it is a milestone in the direction of
bundled, and therefore, more-efficient, operation flows for academic research
institutes and research companies alike. Biotechnology vendors benefit from the
ZAGENO online-platform by reaching potential customers right at the
buying/decision-making moments. They can also leverage ZAGENO as an additional
digital sales channel to increase their reach in the key markets - USA and
Europe. Further, the ZAGENO online-platform represents a valuable marketing tool
to strengthen brand awareness and foster brand image and thus helps industry
players to adapt to existing e-commerce models by increased customer service and
content quality.
Commenting on The Babraham Institute's experience with ZAGENO, Michael Norden,
the Institute's head of purchasing, said, "ZAGENO enables our 200+ scientists to
choose and order life science research products from all vendors using one
platform. This further streamlines our purchasing processes and allows us to
gain full transparency on our spending. Ultimately, scientists focus on their
research while complying with all purchasing requirements. We have found
ZAGENO's customer service to be outstanding."
"ZAGENO combines an exceptional team and is the first to unlock an untapped
billion dollar U.S. market," said Capnamic Ventures General Partner Christian
Siegele.
Founding Partner of Grazia Equity Alec Rauschenbusch commented, "ZAGENO is
fantastic. It's a true game-changer, helping the life science industry become
more successful."
ZAGENO's Pumberger added, "Together with our partners and the Series A funding,
we will strengthen our position at the interface of technology and biotech, as
well as reach our targeted growth in focus markets. We feel very fortunate to
grow together with Capnamic Ventures and Grazia Equity and to benefit from their
deep industry connections and insights. Consistent with entrepreneurial values,
mindsets, and growth targets, we focus on fulfilling customers' needs on all
sides of the platform!"
About Capnamic Ventures
Capnamic Ventures (www.capnamic.com) is one of Europe's leading early-stage
Venture Capital firms, with offices in Berlin and Cologne. The VC invests most
of its funds in tech startups in the German-speaking region. Capnamic also joins
forces with international co-investors. All portfolio companies are supported
through Capnamic's global network of investors and industry partners.
The vast expertise of the Capnamic team includes more than 70 investments, a
high turnover of successful trade sales and IPOs, as well as a strong
entrepreneurial track record within the investment team. The general partners
are Jörg Binnenbrücker ((at)bibrue), Olaf Jacobi ((at)olafjacobi) and Christian
Siegele.
For more details, visit capnamic.com or (at)Capnamic on Twitter.
About Grazia Equity
Grazia Equity, one of Germany's top venture capital firms, has been supporting a
large number of mostly young companies, often from their foundation to the
Initial Public Offering or eventual sale. Grazia's success derives from a
partnership with extraordinarily strong entrepreneurial teams to turn them into
international market leaders. In contrast to other venture capital firms Grazia
has a solid permanent capital structure ("Evergreen"). Grazia's portfolio
companies profit from the entrepreneurial background and the business
development expertise of its partner team as well as a far-reaching
international network. Being active in Germany, Europe and in the USA Grazia has
invested early in category leaders such as Statista, Mister Spex, Conergy,
Quantenna, and Yeay.
For more information, please visit grazia.com
About ZAGENO Inc.
Since its formation in 2015, ZAGENO Inc. sets new standards in the international
biotech market. With the vision to offer an online marketplace connecting
scientists, academic research institutes, and biotech manufacturers, ZAGENO
grows exponentially and represents a milestone for the digitization of science
and research. World-renowned research facilities use ZAGENO for ordering lab
equipment and for optimizing internal processes. The start-up employs 35 staff
members in Boston (USA) and Berlin (Germany). These two locations were selected
to be close to centers known for research advancements and scientific
breakthroughs. For more "EUREKA"-moments - welcome to
ZAGENO: https://zageno.com/
Attachments:
A photo accompanying this announcement is available
at http://www.globenewswire.com/NewsRoom/AttachmentNg/8f25a44f-
43ac-4555-89c9-88e214485457
Attachments:
A photo accompanying this announcement is available
at http://www.globenewswire.com/NewsRoom/AttachmentNg/4121b588-dce2-
4b4c-81f5-1375ea13b05b
Attachments:
A photo accompanying this announcement is available
at http://www.globenewswire.com/NewsRoom/AttachmentNg/b62c1ccf-
4885-4563-813c-5f4596194fd2
Media Contact: Caroline Grossman
(781) 771-5579
Caroline(at)Mirepoixllc.com
Company Contact: Florian Wegener, MD, PhD, MBA, Chief Revenue Officer
ZAGENO Inc.
pr(at)zageno.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ZAGENO, Inc. via GlobeNewswire
Datum: 25.10.2017 - 21:41 Uhr
Sprache: Deutsch
News-ID 565312
Anzahl Zeichen: 8071
contact information:
Town:
Boston
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 298 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ZAGENO on Growth Trajectory - Startup Becoming #1 Online Marketplace for Life Science Research Products; Raises $8 Million"
steht unter der journalistisch-redaktionellen Verantwortung von
ZAGENO, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
